Shopping Cart
Remove All
  • TargetMol
    Your shopping cart is currently empty

PSMA-11

Copy Product Info
😃Good
Catalog No. T28466Cas No. 1366302-52-4
Alias Psma-hbed-CC, PSMA11, HBED-CC-PSMA

PSMA-11 (HBED-CC-PSMA) detects prostate cancer recurrence and metastasis by binding to the extracellular structural domain of prostate-specific membrane antigen (PSMA).PSMA-11 is often used as a tracer of PSMA-expressing tumours in positron emission tomography (PET) scanning by intravenous injection of gallium Ga 68-labelled PSMA-11, Glu-urea-Lys(Ahx) molecule targeted and bound PSMA-expressing tumour cells. After internalisation, PSMA-expressing tumour cells could be detected on PET imaging.

PSMA-11

PSMA-11

Copy Product Info
😃Good
Purity: 99.09%
Catalog No. T28466Alias Psma-hbed-CC, PSMA11, HBED-CC-PSMACas No. 1366302-52-4
PSMA-11 (HBED-CC-PSMA) detects prostate cancer recurrence and metastasis by binding to the extracellular structural domain of prostate-specific membrane antigen (PSMA).PSMA-11 is often used as a tracer of PSMA-expressing tumours in positron emission tomography (PET) scanning by intravenous injection of gallium Ga 68-labelled PSMA-11, Glu-urea-Lys(Ahx) molecule targeted and bound PSMA-expressing tumour cells. After internalisation, PSMA-expressing tumour cells could be detected on PET imaging.
Pack SizePriceUSA WarehouseGlobal WarehouseQuantity
1 mg$147In StockIn Stock
5 mg$372In StockIn Stock
10 mg$519In StockIn Stock
25 mg$929In StockIn Stock
50 mg$1,230-In Stock
100 mg$1,670InquiryInquiry
1 mL x 10 mM (in DMSO)$542In StockIn Stock
Add to Cart
Add to Quotation
In Stock Estimated shipping dateUSA Warehouse[1-2 days] Global Warehouse[5-7 days]
All TargetMol products are for research purposes only and cannot be used for human consumption. We do not provide products or services to individuals. Please comply with the intended use and do not use TargetMol products for any other purpose.
Questions
TargetMol
View More

Batch Information

Select Batch
Purity:99.09%
Appearance:Solid
Color:White
Contact us for more batch information

Resource Download

Product Introduction

PSMA-11 AI Summary
PSMA-11 exhibits potent bioactivity as an inhibitor for various targets with high specificity and selectivity. It shows strong inhibitory action against antiTEV-tagged GCP2 extracellular portion with a Ki value of 0.018 nM, and demonstrates inhibitory activity against antiTEV-tagged GCP3 extracellular portion with a Ki of 13.0 nM, resulting in a high selectivity ratio of 720.0 favoring GCP2. Additionally, PSMA-11 binds to PSMA in human LNCaP cells with a Ki of 12.0 nM and displays 10.63% cell surface binding and 9.47% specific internalization per 10^6 cells. Its HPLC retention time is 1.69 minutes, and it has a logD of -1.71 at pH 7.4. In xenografted mice, the compound shows a tumor to muscle uptake ratio of 4.9 as determined by microPET imaging..
Note: Summary generated by AI. Data source: ChEMBL
Bioactivity
Description
PSMA-11 (HBED-CC-PSMA) detects prostate cancer recurrence and metastasis by binding to the extracellular structural domain of prostate-specific membrane antigen (PSMA).PSMA-11 is often used as a tracer of PSMA-expressing tumours in positron emission tomography (PET) scanning by intravenous injection of gallium Ga 68-labelled PSMA-11, Glu-urea-Lys(Ahx) molecule targeted and bound PSMA-expressing tumour cells. After internalisation, PSMA-expressing tumour cells could be detected on PET imaging.
Targets&IC50
GCP III:0.013 µM(Ki), GCP II:0.012 µM(Ki)
SynonymsPsma-hbed-CC, PSMA11, HBED-CC-PSMA
Chemical Properties
Molecular Weight946.99
FormulaC44H62N6O17
Cas No.1366302-52-4
SmilesOC(=O)CC[C@H](NC(=O)N[C@@H](CCCCNC(=O)CCCCCNC(=O)CCc1ccc(O)c(CN(CCN(CC(O)=O)Cc2cc(CCC(O)=O)ccc2O)CC(O)=O)c1)C(O)=O)C(O)=O
Relative Density.no data available
Storage & Solubility Information
StoragePowder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature.
Solubility Information
DMSO: 90 mg/mL (95.04 mM), Sonication is recommended.
In Vivo Formulation
10% DMSO+40% PEG300+5% Tween 80+45% Saline: 3.3 mg/mL (3.48 mM), Sonication is recommended.
Please add the solvents sequentially, clarifying the solution as much as possible before adding the next one. Dissolve by heating and/or sonication if necessary. Working solution is recommended to be prepared and used immediately. The formulation provided above is for reference purposes only. In vivo formulations may vary and should be modified based on specific experimental conditions.
Solution Preparation Table
DMSO
1mg5mg10mg50mg
1 mM1.0560 mL5.2799 mL10.5598 mL52.7989 mL
5 mM0.2112 mL1.0560 mL2.1120 mL10.5598 mL
10 mM0.1056 mL0.5280 mL1.0560 mL5.2799 mL
20 mM0.0528 mL0.2640 mL0.5280 mL2.6399 mL
50 mM0.0211 mL0.1056 mL0.2112 mL1.0560 mL

Calculator

  • Molarity Calculator
  • Dilution Calculator
  • Reconstitution Calculator
  • Molecular Weight Calculator

In Vivo Formulation Calculator (Clear solution)

Please enter your animal experiment information in the following box and click Calculate to obtain the stock solution preparation method and in vivo formula preparation method:
TargetMol | Animal experiments For example, if the intended dosage is 10 mg/kg for animals weighing 20 g , with a dosing volume of 100 μL per animal, TargetMol | Animal experiments and a total of 10 animals are to be administered, using a formulation of TargetMol | reagent 10% DMSO+ 40% PEG300+ 5% Tween 80+ 45% Saline/PBS/ddH2O , the resulting working solution concentration would be 2 mg/mL.
Stock Solution Preparation:

Dissolve 2 mg of the compound in 100 μL DMSOTargetMol | reagent to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.

Preparation of the In Vivo Formulation:

1) Add 100 μL of the DMSOTargetMol | reagent stock solution to 400 μL PEG300TargetMol | reagent and mix thoroughly until the solution becomes clear.

2) Add 50 μL Tween 80 and mix well until fully clarified.

3) Add 450 μL Saline,PBS or ddH2OTargetMol | reagent and mix thoroughly until a homogeneous solution is obtained.

This example is provided solely to demonstrate the use of the In Vivo Formulation Calculator and does not constitute a recommended formulation for any specific compound. Please select an appropriate dissolution and formulation strategy based on your experimental model and route of administration.
All co-solvents required for this protocol, includingDMSO, PEG300/PEG400, Tween 80, SBE-β-CD, and Corn oil, are available for purchase on the TargetMol website.
1 Enter information below:
mg/kg
g
μL
2 Enter the in vivo formulation:
% DMSO
%
% Tween 80
% Saline/PBS/ddH2O

Dose Conversion

You can also refer to dose conversion for different animals. More Dose Conversion

Tech Support

Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc

Keywords

Related Tags: buy PSMA-11 | purchase PSMA-11 | PSMA-11 cost | order PSMA-11 | PSMA-11 chemical structure | PSMA-11 formula | PSMA-11 molecular weight